Renal Disorder in Systemic Disease Flashcards
Diabetic nephropathy pathology
Hyperglycaemia results in increased growth factors, RAS activation, oxidative stress + advanced glycosylation end products
-> Increased glomerular capillary pressure, podocyte damage + endothelial dysfunction
Glomerulosclerosis and nodule formation (Kimmelstiel-Wilson lesions) and fibrosis are late stage changes
Diabetic nephropathy diagnosis
Microalbuminuria A:CR 3-30mg/mmol, from this stage regression not possible
Diabetic nephropathy management
Keep BP <130/80
Sodium restriction <2g/day (<5g NaCl)
Statins to reduce CV risk
Blood sugar control to prevent development of complications
SLE nephropathy presentation
Can present as nephritis or nephrosis
SLE nephropathy diagnosis
Clinical
Anti-dsDNA and ANA (not specific) Abs
Biopsy if A:CR >30 or P:CR >50
SLE nephropathy treatment
Class I and II show mild changes with little risk of renal progression so anti-RAS drugs and hydroxychloroquine for extra renal disease
Class III-V require immunosuppression
Small vessel vasculitis diagnosis
Clinical
ANCA
Biopsy: rapidly progressive GN without immune deposits
Small vessel vasculitis treatment
High dose glucocorticoids + cyclophosphamide/ rituximab
Plasma exchange if presents with renal failure/pulmonary haemorrhage
Myeloma renal disease treatment
Adequate hydration
Bisphosphonates for hypercalcaemia (beware GFR<30)
Anti-myeloma treatments
Amyloid pathology
Pathological folding of proteins causes extracellular accumulation + organ dysfunction
Classified according to protein
Amyloid diagnosis
Congo red staining goes apple green on biopsy
SAP scan
Haemolytic uraemic syndrome presentation
Microangiopathic haemolytic anaemia and AKI due to thrombosis of glomerular capillaries
In children associated with haemorrhagic colitis due to Shiga toxin producing E. coli (STEC)
Atypical HUS due to complement issues
Haemolytic uraemic syndrome diagnosis
Triad of haemolytic anaemia, decreased platelets and AKI with haemat/proteinuria
Evidence of STEC may be present
Complement abnormalities may be present
Haemolytic uraemic syndrome treatment
STEC-HUS: supportive
aHUS: plasma exchange, eculizumab (anti-C5)
TTP pentad
Fever AKI Neuro symptoms Decreased platelets Microangiopathic haemolytic anaemia